Glinides [Chemical/Ingredient]

Known as: Glinides 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
AIMS To compare the efficacy and safety of new insulin glargine 300 U/ml (Gla-300) with that of glargine 100 U/ml (Gla-100) in… (More)
Is this relevant?
Highly Cited
2014
Highly Cited
2014
OBJECTIVE Insulin degludec/liraglutide (IDegLira) is a novel combination of insulin degludec (IDeg) and liraglutide. This trial… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
Is this relevant?
Review
2012
Review
2012
AIM Most guidelines recommend metformin as first-line therapy in patients with type 2 diabetes. However, the choice of a second… (More)
  • figure 1
  • figure 2
Is this relevant?
2012
2012
BACKGROUND Hyperinsulinemia might be the mechanism leading to an increased cancer risk in patients with type 2 diabetes. The… (More)
  • table 1
  • table 2
Is this relevant?
Highly Cited
2010
Highly Cited
2010
CONTEXT Metformin is the recommended initial drug therapy for patients with type 2 diabetes mellitus (DM). However, the optimal… (More)
  • table 1
  • table 1
  • table 2
  • table 3
Is this relevant?
Review
2008
Review
2008
Glycemic control, a worthwhile goal for people with diabetes, is limited by the barrier of iatrogenic hypoglycemia (1… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2008
Highly Cited
2008
T Endocrinologic and Metabolic Drugs Advisory Committee for the Food and Drug Administration (FDA), of which I am a member… (More)
Is this relevant?
Review
2007
Review
2007
Type 2 diabetes mellitus affects 9.6% of the adults in the United States and more than 200 million people worldwide. Diabetes can… (More)
  • figure 1
Is this relevant?
Review
2004
Review
2004
Insulin secretagogues (sulfonylureas and glinides) increase insulin secretion by closing the ATP-sensitive K+ channel (KATP… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Review
2003
Review
2003
Hypoglycaemic agents such as sulphonylureas and the newer group of "glinides" stimulate insulin secretion by closing ATP… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?